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A B S T R A C T
Metagenomic analysis was originally associated with the studies of genetic material from environmental
samples. But, with the advent of the Human Microbiome Project, it has now been applied in clinical
practices. The ocular surface (OS) is the most exposed part of the eye, colonized by several microbial
communities (both, OS and environmental) that contribute to the maintenance of the physiological state.
Limited knowledge has been acquired on these microbes due to the limitations of conventional
diagnostic methods. Emerging ﬁelds of research are focusing on Next Generation Sequencing (NGS)
technologies to obtain reliable information on the OS microbiome. Currently only pre-speciﬁed
pathogens can be detected by conventional culture-based techniques or Polymerase Chain Reaction
(PCR), but there are conditions to state whether metagenomics could revolutionize the diagnosis of
ocular diseases. The aim of this review is to provide an updated overview of the studies involving NGS
technology for OS microbiome.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Human body is populated with an enormous variety of
bacteria, archaea, fungi and viruses, which form a commensal,
symbiotic and pathogenic community collectively known as
human microbiome [1,2]. The estimated amount of micro-
organisms is in the order of trillions, at least 10 times more than
the number of human cells [1,2]. This evidence has increased the
interest of the scientiﬁc community to understand the role of
these microorganisms in a day-to-day life. A foundation step was
represented by the Human Microbiome Project (HMP), launched
in 2008 by the United States National Institutes of Health, with
the aim to reveal and characterize the microbial populations of
ﬁve main body areas, i.e. gut, mouth, nose, skin and urogenital
tract [3,4]. In the same year, the European Commission granted a
project called MetaHIT, focused on understanding the correla-
tions between human intestinal microbiota and some disorders,
in particular inﬂammatory bowel disease and obesity (http://
www.metahit.eu). Both research programs would have never
been possible without the availability of up-to-date knowledge
and technology, in particular, metagenomics. Metagenomics* Corresponding author at: Fondazione Banca degli Occhi del Veneto, Via
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based on the development of Next Generation Sequencing (NGS)
technology, which overcome the need to separate the genomes
or to culture the microbes. Ideally, NGS can detect all the
microorganisms present in a clinical sample, producing huge
amounts of sequencing data that need to be decoded [5], and has
the potential to improve diagnostic yield, as it is inherently
unbiased and hypothesis-free [6]. Metagenomics has already
shown its efﬁciency by providing a correlation between the
changes in gut microbiota that has found to be associated with
several diseases like cancer, obesity, asthma, atherosclerosis and
diabetes [7–10].
Researches are also aiming at examining the microbiome of
other body areas to understand if microbiome and diseases could
be correlated. One of these areas is the ocular surface (OS), the part
of the eye that is exposed to the environment. Ocular microbiome
could play a key role in the maintaining the physiology of the eye
and its alteration could be correlated with eye disorders, for
example infections [11]. Thus, Shestopalov et al. started the Ocular
Microbiome Project to understand and correlate the ocular
microbiome with ocular disorders [12].
The aim of this article is to review the published literature on
the application of metagenomics in ophthalmology, especially the
knowledge of the OS microbial communities, and the potential
clinical relevance of the NGS approach in the diagnosis of OS
disorders.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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knowledge of the OS disorders and its effective diagnosis, similar to
what has been already found for other body areas?
2. The rise of metagenomics
Metagenomics represents a relatively new discipline in
genomic analysis. It was used initially for detecting the environ-
mental samples [13] however, it has been recently found to be a
useful tool in various areas, including medicine and clinical
practices (Fig. 1). Evolution of NGS technology, also known as high-
throughput sequencing or third-sequencing generation, allowed
its adoption by producing massive sequencing data. Indeed, the
previous Sanger sequencing method was a low-throughput
approach based on dideoxynucleotide chain termination. Although
it was a suitable tool to sequence speciﬁc genes or fragments, but
as was too laborious and expensive, it was difﬁcult to investigate
complex samples due to its sequencing speed, which was only a
few thousand nucleotides per week.
The application of NGS allows sequencing from thousands to
millions of nucleic acid segments simultaneously in a single run.
Thus, allowing to decode important large genomes, such as the
human genome. This also allows full taxonomical proﬁling (“who is
it?”) and compare the functions (“what is it doing?”) of microbial
communities from different areas, in a short span of time
compared to the Sanger method [14].
After sample collection and nucleic acid extraction (DNA or RNA),
the term NGS is genericallyused to indicate the two main sequencing
methods: the marker gene sequencing approach (also called
targeted-amplicon sequencing) and the shotgun approach. In the
former, amplicons from a single conserved gene are produced by
Polymerase Chain Reaction (PCR) (library preparation and cluster
generation). The conserved gene that is most commonly used is the
16S rRNA, because it is ubiquitous and formed from constant and
variable regions that allow the deﬁnition of taxa [15]. In addition, a
universal target for eukaryotic organisms is the 18S rRNA gene.
Moreover, internal transcribed spacer (ITS) regions of rRNA operons
are frequently used to identify fungal species [16]. Targeted-
amplicon sequencing is used mainly in microbiome analysis with
taxonomic purposes. In the shotgun approach, instead, the
sequencing is performed across random fragments of all DNA in aFig. 1. Schematic representation of dgiven sample and can be used also in case of unknown microbial
target. Both methods have advantages and disadvantages. Targeted-
amplicon sequencing is usually used to characterize a particular
microbial group in a sample, while shotgun is the only possible
approach for the identiﬁcation of previously uncharacterized
microbes [17]. Both can be used to detect pathogens, even if
sometimes one type of technique is more appropriate than the other.
For example, if the etiological agent is suspected to be a virus,
shotgun metagenomics is warranted [16], while in the case of a low
biomass sample, marker gene metagenomics may be able to
sequence the infectious agent more adequately [16].
However, metagenomics does not only sequence, but also
interprets the retrieved data and perhaps this is the most critical
step. Indeed, the high-throughput capabilities of NGS approach
leads to an exponential accumulation of sequence data that need to
be interpreted. Hence the requirement to develop increasingly
appropriate bioinformatics tools, i.e. speciﬁc bioinformatics
algorithms that transform raw sequence of NGS signal outputs
in suitable and organized information. Complex and computation-
ally expensive data analysis processes are therefore required [5].
3. OS microbiome: before the NGS adoption
The eye is characterized by an external surface made up of
mucosal tissues. It is exposed to the environment and it is the ﬁrst
defense line of the eye, which is subjected to constant challenges.
Instead the inner part is sterile, with a highly efﬁcient blood-retinal
barrier [18]. The ocular surface (OS) consists of conjunctiva, cornea,
and tear ﬁlm. It is the siteofpossible disorders suchasdryeye, localor
systemic inﬂammations (for example blepharitis, conjunctivitis or
keratoconjunctivitis), autoimmune diseases and infections.
In 1907 Axenfeld ﬁrst attempted to characterize the ocular
microbiome [19]. Since then many studies have been reported
[20,21], but it is still not enough. A deep knowledge of the OS
microbiome (exact composition, function, etc.) could be highly
relevant for diagnostic purposes or to establish correlations with
other diseases, thus understanding the speciﬁc causative agent.
Conventional culture-based techniques are still currently used
for microbial identiﬁcation but, due to their limitations, high
performance diagnostic techniques are being developed and
implemented (PCR and, mostly, NGS). Indeed, with culture-basedifferent areas of Metagenomics.
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(usually in high volumes) have to be performed on a range of
appropriate media. The sensitivity is found to be relatively poor
(yield of 40–70%) [22,23] and the probability of false-positive
results could be signiﬁcant [24]. Results could also be biased due to
the fast-growing microorganisms, which can be easily cultivated
on a standard media [11]. Moreover, studies comparing conven-
tional culture techniques and molecular analysis have shown very
often, that results obtained by these methods are incomplete or
biased by false-positive data, thus highlighting the limitations of
traditional culture-based techniques in terms of sensitivity and
reproducibility [21,25–29]. Graham et al. studied the bacterial
population of 91 subjects classiﬁed as normal or dry eye [30]. The
overall bacterial genera identiﬁed by culture-based techniques led
to the identiﬁcation of a smaller number of organisms compared to
that obtained with PCR and DNA sequencing. Indeed, only
Coagulase negative staphylococci and Bacillus sp were identiﬁed
by culture method while other 8 genera were found by DNA
sequencing, including 5 uncultured bacterial genera.
For these reasons, a comprehensive analysis of the microbial
diversity is usually possible only through the support of innovative
technologies like NGS.
4. OS microbiome: what is currently known?
The microbiome is considered crucial in maintaining the
homeostasis of the OS. The impairments are evident in conditions
such as keratoprosthesis, antibiotic exposure, infectious states and
dry eye [31,32]. As the ocular microbiome and its functions still
remain relatively unknown [33], the continuous improvements in
NGS technologies could lead to an in-depth characterization of the
OS microbial communities and hence serve as a useful tool for the
diagnosis of ocular disease [11], speciﬁcally ocular infections. One
of the main limitations in the diagnosis of ocular disorders has
always been the difﬁculty in obtaining large amount of samples,
due to the delicate anatomy and the eye size. NGS-based approach
would allow characterization of all the genomic content, even
when the available sample size is limited [34,35], sometimes even
less than 2 ng/ml of extracted DNA [12].
A ﬁrst starting point, identiﬁed by Huang et al., is the necessity
to discriminate the commensal microbiota from transient, to
understand their distribution and to better recognize the infective
eye diseases that arise from commensal ﬂora or from an increased
virulence of transient ﬂora [36]. The increased virulence of the
resident pathogens may be the cause of some diseases, as reported
for post-cataract surgery endophthalmitis in which the inﬂamma-
tion was due to the patient’s own conjunctival ﬂora introduced into
the anterior chamber during the surgical practice [37].
There is no general consensus amongst the scientists as some
suggests that age and gender could play an important role in
shaping the OS microbiome and the others don’t. In a study
involving 90 subjects (48 young and 42 old adults) metagenomic
shotgun sequencing was carried out [38]. Samples were obtained
from the inferior bulbar conjunctiva and were analyzed with the
aim to search the microbiome proﬁle differences. A diversity of
bacterial communities between males and females and even a
more signiﬁcant variation in bacterial composition between young
and old adults was found. OS microbiome therefore seems to be a
complex area of research, however, due to novel techniques like
metagenomics, new opportunities and results are being decoded,
although many challenges still needs to overcome.
4.1. Conjunctiva and metagenomics
In 2011, a ﬁrst pilot study involving 4 subjects was conducted
with an aim to explore the bacterial diversity of a healthy humanconjunctiva using 16S rRNA gene amplicon based approach [39].
This study revealed an unpredicted diverse microbial community
(average of 221 phylotypes per individual microbiome, classiﬁed
into 5 phyla and 59 distinct genera), with some ubiquitous genera
that included bacteria known as commensal, environmental and
opportunistic pathogens.
In 2016, using the same NGS technology to analyze 31
conjunctival samples, Huang et al. identiﬁed a high microbial
diversity, classiﬁed into 25 phyla and 526 distinct genera,
providing a framework to investigate the potential roles played
by diverse microbiota and the complex host-microbiome and
microbiome-microbiome interactions [36].
In 2016, Doan et al. applied three complementary techniques
(traditional culture, 16S rDNA deep sequencing and BRiSK, a
metagenomic detection method for DNA-based life forms) to
better characterize microbes and other DNA-based communities in
conjunctival samples of 107 healthy volunteers [25]. They found a
relatively consistent correlation between individuals, principally
formed by Straphylococci, Diphtheroids, Propinibacteria and Strep-
tococci. Interestingly, in 65% of all conjunctival samples tested, they
found Torque Teno Virus, a small DNA anellovirus usually
correlated with several intraocular inﬂammatory conditions (such
as endophthalmitis). This work proved that viruses and microbial
pathogens could populate the OS without necessarily causing
disease. The reason of their presence is yet unknown.
In 2017, the conjunctiva of 45 healthy subjects were sampled at
three time points over three months and processed using culture-
dependent and culture-independent methods (16S rRNA gene
sequencing) with the aim of understanding whether the microbial
communities of the OS change over time [29]. This study
investigated the relationship between microbiome and OS
disorders. They concluded that every single individual has some
constant taxa in OS during an entire life, which were indicated as
“individual-speciﬁc or minimal core microbiomes” [29]. Analyzing
these studies, a rich and various OS microbiome would emerge.
Nevertheless, a contradictory theory doubts that the OS harbors
hundreds of genera of bacteria. The results of the sequencing could
be biased due to the presence of environmental contaminants or
reagents. Salter et al. proved this theory by showing that the
presence of contaminants in extraction kits and laboratory
reagents could impact results obtained from sequence-based
approaches [40]. This event is particularly evident in low biomass
samples, similar to the ocular surface. Hence, concurrent
sequencing of negative control samples is strongly advised [40].
A method validation could thus be one of the major challenges to
overcome in order to allow the introduction of NGS in the clinical
practice.
4.2. Ocular surface microenvironment and dry eye
Dry eye (DE) is a multifactorial disease of the OS and the tear
ﬁlm. The common symptoms are discomfort, visual disturbance
and tear ﬁlm instability with potential damage to the OS and
inﬂammation [41]. In 2016, Watters et al. investigated the ocular
microbiome in patients with DE due to meibomian gland
dysfunction (MGD). MGD is a condition in which the glands that
make the lipid layer of the tears are not functional, allowing the
water phase of the tears to dry out, leading to a DE condition [42].
Although this prospective observational study had several
limitations, mainly the use of conventional culture techniques,
the authors associated the presence of some bacteria, such as
Straphylococcus aureus, with DE, thus establishing an OS micro-
biome-DE correlation.
Zegans et al. hypothesized the possibility of treating inﬂam-
matory diseases caused by OS microbiome dysregulation through
the introduction of appropriate commensal microbes [43]. Indeed,
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treatment strategy in the management of Clostridium difﬁcile
infection [44]. However, no similar evidence has been found for the
eye. A deeper knowledge of changes in the microbiome associated
with inﬂammatory diseases could be a good starting point for
development of new treatment strategies for restoring OS
homeostasis.
4.3. OS microbiome and contact lens wearers
Shin et al. investigated the correlation between the contact lens
wearers to the microbiome changes [33]. They analyzed the
bacterial communities of the conjunctiva and the skin under the
eye of 20 subjects (9 lenses wearers and 11 non-lenses wearers) by
a 16S rRNA gene-base sequencing technique. They found that the
OS microbiota of lens wearers is different from that of non-
wearers, and that the lens wearers have the conjunctival micro-
biota more similar to that of the skin. Particularly, they reported
that lens wearers had a higher abundance of Methylobacterium,
Lactobacillus, Acinetobacter, Pseudomonas and a lower abundance of
Haemophilus, Streptococcus, Staphylococcus and Corynebacterium
compared to non-lens wearers. However, they recommended
further research to demonstrate that the microbiome structure
provides less protection against pathogens [33]. Additionally, they
reported that anesthetic eye drops used before sampling reduced
the detected ocular microbiota diversity, thus biasing the results
obtained.
In another study, conjunctival microbial communities in
contact lens wearers (soft contact lens and orthokeratology lens)
and non-contact lens wearers were compared using an amplicon
sequencing approach [31,32]. Microbiome in the two groups was
found relatively similar, though differences between orthoker-
atology lens wearers and non-wearers were greater than those in
the soft contact lens group.
By examining these two studies [31–33], Boost et al. concluded
that the use of contact lenses has a fairly small impact on the
microbiome changes of healthy subjects when compared to the
proteome [20] (i.e. the whole set of proteins expressed by an
organism). Nevertheless, this “fairly small impact” has been
possible to detect only with the use of NGS (possibly not
achievable with conventional techniques). Moreover, the use of
contact lenses has been associated with an increased susceptibility
and risk of infection, such as microbial keratitis [20], therefore it
should be diagnosed and treated relatively.
4.4. OS and antibiotics
Antibiotics are normally used to kill the pathogens. Broad-
spectrum antibiotics or a cocktail of drugs (antibiotics, antivirals,
antifungals) are generally empirically administered especially in
those cases where mixed diagnoses occur. However, the antibiotics
must be chosen carefully and therefore knowing the causative
microorganism could be highly desirable. Overuse of antibiotics for
OS may increase resistance and the ocular microbial communities
could be damaged, resulting in a greater susceptibility of the OS
[36]. In an animal study, the corneas of gentamycin-treated mice
(corneas with reduced commensals – reduction induced by
antibiotic treatment) had more severe susceptibility to P.
aeruginosa-induced keratitis compared to control mice (corneas
with commensals – untreated mice) [21]. This study showed that
the ocular ubiquitous microbiota contributed to the resistance
towards infection. The loss of OS microbiota homeostasis could be
dangerous. A speciﬁc therapy is possible only when the exact
nature of the etiological agent is known. Additionally, the microbial
communities that play a protective function for the eye has to be
preserved. World Health Organization is urging all countries toplan actions to reduce the misuse of antibiotics and minimize the
increase in resistance (http://www.who.int/antimicrobial-resis-
tance/en/) towards antibiotics. Moreover, a targeted therapy could
decrease the cost and time of treatment, leading to a social and
economic impact. Lastly, a promising application of NGS could be
the characterization of antibiotic resistance directly from clinical
samples in order to ﬁnd the best therapeutic approach [45].
4.5. Metagenomics in OS diagnostics
Few studies have been performed to understand if metage-
nomics could be a reliable diagnostic tool in management of eye
infection and OS diseases. The premises are interesting. Even if not
directly related to the OS, a recent study by Gonzales et al. showed
the practical use of metagenomics in ophthalmology [46]. They
studied two cases of intraocular lymphoproliferative disorders
using a metagenomic deep sequencing approach. It was possible to
detect the infectious pathogen that drive intraocular lymphomas
as well as common and rare cancer associated mutations, using
small amounts of aqueous ﬂuid as samples.
A Chinese woman in New York with erythema, swelling in her
body and red sore eyes did not have a proper diagnosis using
conventional methods [47]. However, with an unbiased meta-
genomic approach using DNA samples obtained from her eyes and
subcutaneous tissue, it was possible to establish that the patient
suffered from Malayan ﬁlariasis.
Li et al. evaluated 16 cases of infectious keratitis and 4 controls
in formalin-ﬁxed corneas by NGS to identify pathogens from
corneal specimens [28]. They were able to establish the feasibility
of using metagenomics to investigate bacteria, fungi, amoeba, and
viruses associated with pathogenic corneal infections.
Doan et al. showed that metagenomic DNA sequencing is highly
concordant, but better than pathogen-directed PCR [26]. This
conclusion was obtained analyzing 31 PCR-positive samples and 36
PCR-negative samples by DNA sequencing.
In a recent study, Kirstahler et al. examined vitreous samples
from patients with endophthalmitis following cataract surgery or
intravitreal injection [48]. They designed the experiment by
comparing two DNA isolation procedures and then carried out
metagenomic analysis. For 12 out of 14 patients, the dominant
etiologic agent was identiﬁed: Staphylococcus epidermidis for six
patients, Enterococcus faecalis for two patients, Serratia marcescens
for one patient, Paenibacillus spp. for one patient and Staphylococ-
cus hominis for one patient. Therefore, they concluded that
genomic-based analyses of human ocular body ﬂuid specimens
can provide actionable information related to infectious disease
management. In addition, they established that it is possible to
identify antibiotic-resistant genes through the analysis of whole
genome sequences [48].
Perhaps the most representative result that links metagenom-
ics to the diagnosis of OS infections was obtained by Doan et al. in a
study involving patients with uveitis [6,25]. They examined 6
intraocular ﬂuid samples – 5 from subjects with known diagnoses
and one from a subject with bilateral chronic uveitis without a
known etiology. Using metagenomic deep sequencing approach,
diagnoses-conﬁrming results were obtained and, more important-
ly, the identiﬁcation of the causative agent of chronic uveitis
(unknown etiology) was possible. In this study, NGS has proven to
be a highly effective technology, especially when the other
conventional methods failed.
One of the most crucial limitations of using metagenomics data
is that the downstream bioinformatics data reveals extensive
results. This generates huge amount of data, which becomes
difﬁcult for a clinician to record and analyze on a routine basis. For
the clinicians, however, it would be more appropriate to have a
decoded result to understand the exact OS disorder etiology. Only
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processing exclusively the required data with the resistance proﬁle
could potentially transform metagenomics as a practical solution
and a widespread technique. The use of metagenomics in an
ophthalmic practice has thus been speculatively illustrated in
Fig. 2.
5. Conclusions and future perspectives
The ocular microbiome contributes to the normal physiological
state of the eye and any alteration disturbs the homeostasis,
leading to disorders. The current trend is to ﬁnd new target speciﬁc
diagnostic approaches leading to new therapies, as the traditional
techniques are only limited to the detection of pre-speciﬁed
pathogens. Currently, in case of ocular infections, a widespread
possibility is to take a corneal scrape and use it for culture-based or
PCR investigations. However, often there are no results (more than
50% of all presumed intraocular infections do not have an identiﬁed
pathogen) [23]. Meanwhile, patients undergo a broad-spectrum
therapy based on empirical treatment. The implementation of
metagenomics in a clinical setting appears to be promising [49] as
NGS could detect all the agents present in a clinical sample [50],
with absolute numbers without any hypothesis. We anticipate that
if technologies like NGS becomes a standard diagnostic assay, it
will be easier to identify key microbes of the disease (even if these
are rare pathogens). Of all the disorders previously analyzed, ocular
infections represent a signiﬁcant example, as they could be treated
with appropriate and targeted therapies. However, many chal-
lenges still remain. Sequencing data need to be decoded by
advanced bioinformatics tools to correctly interpret the informa-
tion found. Furthermore, a validation of the method is necessary to
avoid interferences by the extraction kits and the laboratory
reagents. Eventually, it is desirable that randomized clinical trials,
able to show the beneﬁcial effect of metagenomics, are developed.
A ﬁrst workable strategy to design a clinical trial could be the
combined use of NGS with traditional approaches, to have a cross-
control between various techniques and conﬁrmed results,
although this may not be enough. Data interpretation costs haveFig. 2. The process towards genetic guided treatment in the ﬁeld of ophthalmology. The
sample preparation, sequencing, bioinformatics, analysis and report writing, indicat
metagenomics guided eye treatment on the patient. Being highly speciﬁc and cost effecto be signiﬁcantly reduced (currently the estimated overall cost is
of several hundreds to thousands of dollars per sample analyzed)
[51] and data interpretation times shortened. It seems too early to
expect routine use of NGS, however, it deﬁnitely has potential to
overcome the traditional diagnostic methods in the very near
future. No cases of randomized clinical trials have been reported so
far however, it is hoped to be available soon. Chiu et al. hypothesize
that over the next 5 years, prospective clinical trial data evaluating
the utility and cost-effectiveness of metagenomics will become
available [51].
Recently, we used next-generation sequencing, mainly 16S and
18S, for the detection of microorganisms present in human donor
corneal preservation medium. We found that metagenomics
technique provides complete taxonomic proﬁling unlike the
conventional methods. Although all the genomic material of the
organisms was detected, it was difﬁcult to ﬁnd live and active
microbes that could have affected the preservation media. We also
noted that the costs and the turn-around time need to be reduced
signiﬁcantly, and the detection of viable organisms would be
necessary to introduce this technology in routine clinical practice
[52], as currently, the NGS technique detects all the genomic
material available in the sample. One of the major limitations of
next-generation sequencing for the OS is that OS harbors hundreds
of bacterial genera. There are chances that mostly the sequencing
results would represent environmental contaminants. This is true
for low biomass samples, such as conjunctival samples. However,
similar to Shestopalov et al. [12] we have also found that only
<2 ng/mL volume of the sample could be enough to obtain a full
genome sequencing result. However, it has been noted that
sampling and the technology in itself needs a higher degree of
standardization before putting it into clinical practice.
Further investigations of the OS microbiome and continuous
use of NGS technologies for diagnostic purposes are required to
consolidate the method and introduce it into the clinical practice,
preferably according to validated and standardized protocols.
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